Thiabendazole

噻苯达唑

Report date: 2025/02/09 20:00:08
NME

Base Information

Drug NameThiabendazole
Drug Alias NameTiabendazole噻苯咪唑噻苯哒唑2-(噻唑-4-基)苯并噻唑Mintezol +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 1A2 inhibitors
TargetsCytochrome P450 1A2
Therapy Area/IndicationsBurnsDracunculiasisLarva Migrans +[4] 
Global Approved IndicationsDracunculiasisLarva MigransToxocariasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1967/04/07
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesNeoMatrix Therapeutics Inc
Inactive CompaniesMerck & Co Inc
Active IndicationsBurns
Inactive IndicationsDracunculiasisLarva MigransToxocariasis

Other Information

ATC CodeD01AC06P02CA02
Related LinksWikipediaDrugBankKEGG